Martin Makary outlines AI plans and the broader vision for his term as FDA commissioner
WASHINGTON, D.C.—Speaking at the annual Food & Drug Law Institute conference in Washington, D.C., Martin Makary, M.D., said implementing AI is one of the agency’s top priorities.
